Mia Injectable Breast Implants Arrive in the UK
Mia is a patented, minimally-invasive breast harmonisation surgery promising accessibility and ease underpinned by clinical excellence. Now, marking a significant and highly anticipated moment in the field of breast harmonisation surgery, this breakthrough procedure has now launched in the UK. Deemed internationally as the future of breast surgery, Mia offers a unique experience that brings balance and harmony while removing many of the obstacles of traditional breast surgery.
Representing what can only be described as the future of surgery, Mia signifies a paradigm shift in the way surgeries are not only performed but also experienced. By integrating state-of-the-art technology and cutting-edge techniques, Mia redefines the surgical experience, empowering surgeons and patients alike in the process.
Many women are looking for safe alternatives to breast augmentation but have previously not been able to find solutions that speak to them. Mia® enables patients to increase the volume of their breasts by up to two cup sizes while fully preserving the breast tissue for an incredibly natural and harmonious result. This minimally invasive surgery is performed in just a ninety minute journey - with the procedure itself often taking just fifteen minutes. With a unique and innovative technique - and no need for general anaesthetic - patients can expect low postoperative pain associated and a small, concealed scar in the axilla; overcoming many of the reservations patients may currently share while considering breast harmonisation.
Practically pain-free, the insertion of the implants is based on a unique, patented, high-tech system with preservation of the breast tissue. Throughout this minimally invasive surgical procedure, the tissue is gently pushed aside by a balloon through a small incision in the armpit; creating the space for the implant and meaning that the tissue is fully preserved - a positive for patients looking to breastfeed in the future.
The implant is then inserted into the breast using the brand’s innovative “no-touch technique”; the only true "no-touch" technique on the market, utilising an injector for implant insertion where the implant is then never touched.
Award-winning British and Internationally trained Plastic and Cosmetic Surgeon, Mr Paul Banwell is one of the very first plastic surgeons in the UK to offer this highly anticipated minimally invasive surgery.
He said, ‘I am thrilled to be one of the first surgeons in the UK to help introduce Mia to the country - and I have no doubt that this will enhance the current landscape of plastic surgery.
‘With the first-ever injectable implants and this revolutionary technique, Mia® not only offers what is a very natural look with a one to two-cup proportionate result, but also offers a myriad of benefits to the patient - including a shorter treatment time, no requirement for general anaesthesia, very low postoperative pain and only a small, concealed scar in the armpit. This represents a new paradigm in breast aesthetics, offering patients the opportunity to replace a push up bra with a revolutionary local anaesthetic technique - a very exciting advancement.
‘Mia complements our existing surgical offering as we continue to offer our patients innovative treatments that are underpinned by clinical excellence, greater accessibility, and peace of mind. I look forward to working with Mia and continuing to offer the highest quality care to my patients.’
As part of the rollout of Mia's innovative breast harmonisation technology in the UK, a full-warranty program is offered to further ensure patient satisfaction and peace of mind. This
program supports those considering the option to reverse their procedure, highlighting Mia's commitment to flexible and patient-centric care solutions.
In alignment with this patient-first approach, the Adoreal platform offers a very strategic partner, enhancing the Mia initiative with a focus on consumer-led aesthetics. This collaboration amplifies the commitment to empowering patients, placing them at the centre of their aesthetic journey. Adoreal facilitates what can only be described as a personalised approach, offering continuous support and enabling ongoing dialogue between patients and healthcare providers from the initial consultation through recovery.
The platform improves communication, gives patients the ability to visualise their outcomes in 3D from the comfort of their home and sends reminders to guide the patient through each step of their treatment plan. “Adoreal is the culmination of decades of experience working in every aspect of the aesthetics industry, solving unmet needs that had not been understood or solved before” explains Johan Andersson, Co-Founder and President of Adoreal. “We felt consumers in aesthetics deserved something drastically better, something built with their needs as the guiding force. Adoreal is not solving a problem due to a lack of care, expertise or willingness. Adoreal is solving for predictability, trust, scalable experiences and is creating a consumer-led dialogue. Traditional methods just don't cut it anymore.
Patients can find a clinic via Adoreal.
